Genmab — November 2018
-
Hvad er Lancet Oncology?
-
Ok. Glimrende:) Tak.
-
De er også blevet spurgt om partnerskab fra BP og Biotech ifm DR5/DR5 Hexabody som er 100x mere potent end det eksisterende. Hvilken Biotech kan løfte den opgave ? Han siger de venter med parterskab til den er i klinikken, så prisen er højere (for partnerskab)

-
Efter 39,5 md er den mediane ikke nået endnu, undtagen for højrisiko pts. https://ash.confex.com/ash/2018/webprogram/Paper112697.html
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
